Materials today. Bio · 2026
CXCR4+ circulating tumor cells (CTCs) accumulate in subcutaneous, immune suppressive, CXCL12-loaded-hydrogel.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Portella Luigi, Di Febbraro Dario Guido, Righelli Dario, Bertolini Giulia, Guardascione Giuseppe, Rea Giuseppina, D'Alterio Crescenzo, Ieranò Caterina, Santagata Sara, Trotta Anna Maria, Gentili Marco, Sulsenti Roberta, Luciano Antonio, Palma Giuseppe, Bruzzese Francesca, Parisi Ilaria Assunta, De Luca Antonella, Roz Luca, Pacelli Roberto, Scala Stefania
Аннотация
Circulating tumor cells (CTCs) sensing the chemokine CXCL12 and invading hyaluronic acid hydrogel (CXCL12 loaded hydrogel, CLG) might display metastatic attitude. CLG recovered-human lung (H460, A549), and ovarian cancer cells (IGROV-1) overexpressed the CXCL12 receptor, CXCR4, developed larger spheres and activate transcriptional programs of invasion and stemness. Interestingly, CLG-U87 glioblastoma cells highly expressed EpCAM and significantly upregulated the very specific NGFR, NTS, AQP1 and CMKLR1 genes, associated with cell proliferation, migration/invasion and metastasis. In a syngeneic model, subcutaneous CLG significantly attracted GFP-Lewis lung carcinoma (LLC) cells impairing lung colonization within 4 h from cell injection and up to twenty-one days. In lung, M1 macrophages rapidly increased post cancer cells injection while M2 prevailed after 10 days (T10). Neutrophils (Ly6Ghigh and Ly6Glow) infiltrated the lungs after ten days from cells injection with late expansion of immature Ly6Glow. According to lung niche, Empty gel (EG) and CLG were early infiltrated by macrophages and later by neutrophils. CLG generated an immunosuppressive environment defined by M1/M2/Ly6Glow able to capture and divert metastatic CTCs from the lung colonization.